Adaptimmune Therapeutics plc
Home
Our Company
Overview
arrow_forward
Partners
arrow_forward
Board of Directors
arrow_forward
Leadership Team
arrow_forward
Scientific Advisory Board
arrow_forward
Perspectives
arrow_forward
Pipeline
Clinical Pipeline
arrow_forward
Afami-cel
arrow_forward
ADP-A2M4CD8
arrow_forward
Preclinical Pipeline
arrow_forward
Technology
Overview
arrow_forward
Manufacturing
arrow_forward
Publications
arrow_forward
Patients & Families
Overview
arrow_forward
Taking Part in Our Clinical Trials
arrow_forward
Cancer Info
arrow_forward
Videos
arrow_forward
Engagement with Patient Organizations
arrow_forward
Clinical Trials
Overview
arrow_forward
Expanded Access Policy
arrow_forward
Investors & Media
Overview
arrow_forward
News Center
arrow_forward
Financial Info and Governance
arrow_forward
Stock Data
arrow_forward
SEC Filings
arrow_forward
Contact
Careers
Overview
arrow_forward
US Careers
arrow_forward
UK Careers
arrow_forward
Search
Press Releases
Investors & Media
Investors & Media
Overview
News Center
Media
Corporate Presentations
Press Releases
Publications
Events
Email Alerts
Financial Info and Governance
Company Information
Leadership Team
Financial Results
Income Statement
Balance Sheet
Cash Flow
Board of Directors
Board Committees
Governance Documents
Annual Shareholder Meeting
FAQ
Contacts
Adaptimmune Ltd Report
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
News Center
Media
Corporate Presentations
Press Releases
Publications
Events
Email Alerts
Year
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
Category
All Releases
Financial Releases
Search terms
Search News
May 11, 2015 11:49am EDT
Adaptimmune Announces Closing of Initial Public Offering
May 06, 2015 7:00am EDT
Adaptimmune Announces Pricing of Initial Public Offering
Prev
1...
16
17
18
19
20
21
22
23
24
25
